Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BONESUPPORT HOLDING AB (DE:2B4)
:2B4
Holding DE:2B4?
Track your performance easily
Earnings Data
Report Date
Feb 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2018
|% Change Since: 12.22%
|Next Earnings Date:Jul 26, 2018
Earnings Call Sentiment|Positive
Bonesupport's Q3 2024 earnings call highlighted robust sales growth, particularly for CERAMENT G in the U.S., and successful clinical outcomes from the SOLARIO study. While there were some challenges in Europe and currency impacts, the overall sentiment is largely positive due to strong market performance and promising future prospects.Company Guidance
During the BONEX.ST Q3 2024 earnings call, CEO Emil Billbäck and CFO Håkan Johansson provided guidance highlighting a robust quarterly performance with key metrics indicating strong growth. Sales for Q3 reached SEK 238 million, marking over a 50% year-over-year increase, with constant currency growth at 54%. The quarter saw a record operating result of SEK 48 million before incentive provisions, and a reported EBIT of SEK 41 million. Additionally, the company experienced an organic cash increase of SEK 39 million, bringing the total to SEK 153 million. Notable achievements included significant market penetration of CERAMENT G in the U.S., with sales of SEK 134 million and a year-over-year growth of 114%, now representing 50% of total quarterly sales. Sales in North America grew by 59% reported and 63% at constant exchange rates, while Europe and the rest of the world reported a 22% sales increase. The SOLARIO study was emphasized as a pivotal milestone, showcasing the potential to reduce systemic antibiotic treatment significantly, which could alter treatment protocols. The company continues to prepare for its entry into the Spinal Fusion market and anticipates further growth opportunities.Record-Breaking Revenue and Growth
Q3 sales reached SEK 238 million, showing a reported growth of over 50% year-over-year and 54% in constant exchange rates.
Strong Operating Results
Operating results before incentive provisions were SEK 48 million, with a reported EBIT of SEK 41 million.
Significant Cash Flow Improvement
A strong organic cash boost of SEK 39 million increased cash to SEK 153 million.
CERAMENT G U.S. Market Performance
Sales of CERAMENT G in the U.S. reached SEK 134 million, showing a 114% growth year-over-year.
SOLARIO Study Success
The SOLARIO study met its primary endpoint, showing potential to reduce systemic antibiotic treatment duration significantly.
---
DE:2B4 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:2B4 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 24, 2024 | €28.96 | €29.92 | +3.31% |
| Jul 11, 2024 | €24.90 | €23.64 | -5.06% |
| Apr 25, 2024 | €20.94 | €20.20 | -3.53% |
| Feb 15, 2024 | €18.06 | €17.34 | -3.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does BONESUPPORT HOLDING AB (DE:2B4) report earnings?
BONESUPPORT HOLDING AB (DE:2B4) is schdueled to report earning on Feb 25, 2025, TBA Not Confirmed.
What is BONESUPPORT HOLDING AB (DE:2B4) earnings time?
BONESUPPORT HOLDING AB (DE:2B4) earnings time is at Feb 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of BONESUPPORT HOLDING AB stock?
The P/E ratio of BONESUPPORT HOLDING AB is N/A.
What is DE:2B4 EPS forecast?
Currently, no data Available
---